New Jersey Legalizes Recreational Marijuana: Employer Obligations

What New Jersey’s Recreational Marijuana Law Changed

New Jersey voters approved adult-use cannabis legalization in 2020. The state then enacted the Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Act, commonly called CREAMMA or the CREAMM Act, in 2021.

Under the law, adults who meet the age requirement may purchase and use regulated cannabis, subject to restrictions on where and how it may be consumed. Legalization did not create a right to smoke during a staff meeting, store edibles beside the communal coffee creamer, or operate machinery while impaired.

For employers, the most important employment provisions generally prohibit refusing to hire, discharging, or otherwise taking adverse action against a person simply because that person uses or does not use cannabis. Employers also should not make an employment decision solely because a test detects cannabinoid metabolites resulting from legally permitted conduct.

Legal use is not the same as workplace permission

Employers may still prohibit employees from possessing, consuming, selling, transferring, or being impaired by cannabis during working hours or on company property. They may enforce safety rules, investigate accidents, conduct legally permitted tests, and discipline employees for proven violations of a properly written workplace policy.

The practical dividing line is conduct and impairment, not personal approval. A supervisor may dislike cannabis, anchovies, or motivational posters featuring mountain climbers. Personal preference is not a defensible employment standard.

Core New Jersey Employer Obligations

Do not rely on a positive cannabis test alone

Cannabis metabolites may remain detectable after the intoxicating effects have ended. Consequently, a positive urine or other bodily-fluid test can show previous exposure without proving that a person was impaired while performing job duties.

The New Jersey Cannabis Regulatory Commission’s workplace guidance states that a scientifically reliable test showing cannabinoid metabolites, by itself, is insufficient to support adverse employment action. Employers should combine testing with documented physical signs, behavioral observations, or other credible evidence of impairment during prescribed working hours.

This is especially important during pre-employment screening. An employer may maintain a testing program, but rescinding an offer solely because an applicant tests positive for cannabis creates substantial legal risk. The test may reveal lawful weekend conduct rather than anything relevant to Monday morning performance.

Maintain a clear drug-free workplace policy

Every New Jersey employer should review its handbook, offer letters, testing forms, accident procedures, and disciplinary rules. The policy should clearly state that the organization prohibits on-duty use, possession, distribution, and impairment rather than broadly declaring that any cannabis use automatically results in termination.

A compliant policy should explain:

• What conduct is prohibited during working hours and on company property.
• When pre-employment, random, reasonable-suspicion, or post-accident testing may occur.
• How the organization documents suspected impairment.
• Who may order a test or remove an employee from duty.
• How employees may respond to a positive result.
• When federal requirements apply to particular positions.
• How testing and medical information will be kept confidential.

Policies should also cover remote work, business travel, company vehicles, client locations, and off-site events. Working from a kitchen table does not turn working hours into personal time.

Train supervisors to recognize and document impairment

Supervisors should not diagnose cannabis impairment based on stereotypes, rumors, hairstyle, personality, or an employee’s enthusiastic discussion of snack foods. They need objective training and a consistent observation process.

The NJ-CRC’s interim guidance recommends designating a trained staff member or qualified third-party contractor to assist with suspected impairment evaluations. It also recommends using a uniform reasonable-suspicion observation report completed by the employee’s supervisor together with another trained representative or second manager.

Observations may include changes in coordination, balance, speech, alertness, reaction time, behavior, appearance, or the ability to perform ordinary tasks. Reports should describe what observers actually saw, heard, or smellednot conclusions such as “looked high.”

Employers may also consider scientifically valid cognitive impairment testing, standardized automated assessments, or ocular scans where appropriate. Any technology should be validated, consistently administered, privacy-conscious, and reviewed by counsel before implementation.

When May a New Jersey Employer Test for Cannabis?

CREAMMA permits drug testing in several employment situations, including pre-employment screening, random testing programs, reasonable suspicion of workplace use or impairment, and investigations following certain work-related accidents.

Permission to conduct a test does not automatically create permission to fire someone based on the result. Testing is one piece of the investigation, not the entire puzzle.

Reasonable-suspicion testing

When an employee displays observable signs of impairment, the employer should promptly document the circumstances. Whenever possible, two trained observers should independently record their findings before discussing them with each other. The employer may then arrange testing under its written policy.

An employee who may be impaired should be removed from safety-sensitive duties while the situation is evaluated. The employer should also arrange safe transportation rather than allowing the individual to drive away. Sending a potentially impaired employee into traffic with a cheerful “keep us posted” is not a safety program.

Post-accident testing

A workplace accident may justify testing when the employer conducts a genuine investigation under a consistently applied policy. Automatic testing after every minor incident can create problems when there is no reasonable connection between possible impairment and the event.

Employers should document the accident, identify witnesses, preserve relevant video or equipment data, record observable signs, and explain why testing was ordered. Occupational safety, collective bargaining, privacy, and federal testing requirements may also apply.

The 2026 Sanders Decision Raises the Stakes

New Jersey employers received an important warning on May 26, 2026, when the state Appellate Division issued its published decision in Sanders v. The Levari Group, LLC.

The case involved a job applicant whose conditional offer was allegedly withdrawn after a pre-employment test detected cannabis metabolites. The appellate court concluded that CREAMMA provides an implied private right of action, meaning applicants and employees may sue employers directly for alleged violations of the statute’s cannabis-related employment protections.

The decision departed from the federal Third Circuit’s 2024 ruling in Zanetich v. Walmart Stores East, Inc., which had predicted that New Jersey law did not create such a private remedy. Federal and state decisions therefore reached different conclusions about the same state statute.

For practical compliance purposes, employers should follow the more cautious approach created by Sanders. Unless the New Jersey Supreme Court or Legislature changes the rule, a person alleging that an employer acted solely because of lawful cannabis use or a positive cannabis result may attempt to recover damages through a private lawsuit.

The lesson is straightforward: A hiring manager should not see “THC positive,” click “reject,” and move on to lunch. The employer should determine what rule applies, whether federal law controls, whether medical use is involved, and whether the decision rests on evidence other than metabolite presence.

Medical Cannabis Creates Additional Duties

Medical cannabis cases require a separate layer of analysis. New Jersey’s Jake Honig Compassionate Use Medical Cannabis Act provides employment protections and procedures that may apply when an employee or applicant tests positive.

When an employer with a drug-testing policy receives a positive cannabis result, the medical-cannabis law generally requires written notice offering the employee or applicant an opportunity to provide a legitimate medical explanation. The individual ordinarily has three working days after receiving the notice to submit supporting information or request a retest of the original specimen at the individual’s expense.

An employer may also have obligations under the New Jersey Law Against Discrimination. In Wild v. Carriage Funeral Holdings, Inc., the New Jersey Supreme Court allowed disability-discrimination claims involving authorized medical cannabis use to proceed.

Employers should therefore consider whether the employee has an underlying disability, whether an accommodation request has been made, and whether an interactive discussion is required. Possible accommodations may involve schedules, leave, transfers, or adjustments that do not create an undue hardship.

Employers are not generally required to permit cannabis consumption or impairment during work. The accommodation analysis concerns disability-related needs and lawful treatment, not permission to perform a dangerous job while impaired.

Federal Rules May Override State Protections

New Jersey legalization does not change federal testing rules for federally regulated transportation positions. Employees performing safety-sensitive duties covered by the U.S. Department of Transportation remain subject to federal marijuana testing requirements.

A verified positive DOT test requires immediate removal from safety-sensitive functions and completion of the federal return-to-duty process before the employee may resume those duties. Medical or recreational authorization under New Jersey law does not convert a positive DOT marijuana test into a negative result.

Federal contracts, grants, licenses, and industry regulations may create additional obligations. CREAMMA recognizes that employers may need to revise their prohibitions when compliance with the state rule would cause a provable conflict with federal requirements.

Employers should not assume that every vaguely “safety-sensitive” job is automatically exempt from New Jersey protections. The organization should identify the specific federal statute, regulation, contract term, or licensing rule on which it relies.

A Practical Compliance Checklist for Employers

1. Audit existing policies. Remove language that automatically penalizes any cannabis use or positive THC result.
2. Separate state and federal positions. Identify DOT-regulated jobs and roles governed by specific federal contracts or licenses.
3. Review pre-employment screening. Decide whether cannabis testing remains necessary for each position and prevent automatic rejection based solely on metabolites.
4. Create an impairment protocol. Adopt a reasonable-suspicion form and define who may conduct observations.
5. Train at least two decision-makers. Supervisors and HR representatives should understand observable signs, documentation, confidentiality, and escalation procedures.
6. Build a medical-response process. Provide required written notices and allow the applicable response period after positive tests.
7. Protect medical information. Store test results and accommodation records separately from ordinary personnel files.
8. Apply rules consistently. Similar facts should produce similar procedures regardless of the employee’s position, popularity, age, race, disability, or other protected status.
9. Review serious decisions. Obtain legal guidance before rescinding an offer, terminating employment, or imposing major discipline based on cannabis-related facts.

Conclusion: Focus on Workplace Conduct, Not Lawful Private Choices

New Jersey recreational marijuana legalization did not eliminate an employer’s ability to protect workers, customers, equipment, and the public. It changed the evidence employers need before taking action.

The safest approach is to regulate performance, safety, possession, on-duty use, and demonstrated impairment. A positive test should support a properly documented investigation rather than replace one. Employers should also provide medical-cannabis procedures, respect federal requirements, and update policies as New Jersey courts continue interpreting CREAMMA.

Following the 2026 Sanders decision, outdated “zero tolerance means automatic termination” policies are particularly risky. A thoughtful policy may not be as catchy as a slogan printed in capital letters, but it is far more useful when an employment decision reaches a courtroom.

Practical Employer Experiences and Lessons

The following composite examples illustrate common situations New Jersey employers may encounter. They are not accounts of specific clients or substitutes for individualized legal advice.

Experience One: The warehouse applicant with a positive result

A distribution company makes a conditional offer to an applicant for a general warehouse position. The applicant completes the company’s standard drug screen, which reports cannabis metabolites. No interview behavior suggested impairment, and the position is not subject to DOT testing or another identified federal rule.

An outdated hiring system automatically marks the applicant as ineligible. That process creates the exact type of risk highlighted by Sanders. The employer should pause the decision, determine whether the result reflects medical use, provide any required notice, and avoid withdrawing the offer solely because cannabis metabolites were detected.

The broader lesson is that compliance cannot live only in the employee handbook. Applicant-tracking software, laboratory instructions, recruiter scripts, and background-screening vendors must follow the same policy.

Experience Two: The forklift operator behaving unusually

A forklift operator arrives with slowed responses, poor coordination, unusually confused speech, and difficulty completing a routine safety inspection. One supervisor suspects cannabis use. Rather than immediately announcing a verdict, the supervisor contacts a second trained manager.

Both managers separately document specific observations. They remove the operator from equipment duty, arrange transportation, complete the company’s reasonable-suspicion report, and order testing under the written policy. The decision is based on observable workplace impairment and safety concerns, supported by testingnot on the test alone.

This approach protects the workforce and produces a clearer record. It also reduces the chance that discipline will look like guesswork dressed in a necktie.

Experience Three: The employee authorized to use medical cannabis

An office employee tests positive after a uniformly administered random test. After receiving written notice, the employee provides medical-cannabis documentation and explains that treatment occurs outside working hours for a chronic condition. The employee has no performance problems or observed signs of impairment.

HR should not treat the authorization as a complete answer or an automatic reason for discipline. It should review the medical-cannabis procedure, consider disability-law obligations, protect the employee’s confidential information, and discuss any accommodation that may be necessary. The employer may continue prohibiting use and impairment during work while respecting lawful treatment outside work.

Experience Four: The commercial driver covered by DOT rules

A New Jersey employee who drives a commercial vehicle in a federally regulated position tests positive for marijuana under a DOT program. The employee explains that recreational cannabis is legal in New Jersey and was consumed while off duty.

Here, federal transportation rules control the safety-sensitive function. The employer must immediately remove the employee from covered driving duties and follow the required federal process. State legalization does not excuse the federal result.

The experience demonstrates why one universal policy rarely works. A receptionist, warehouse associate, remote accountant, and DOT-regulated driver may all work for the same company while being subject to different cannabis-testing rules. Position-specific procedures, careful documentation, and trained decision-makers are the practical ingredients of a defensible New Jersey workplace program.